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MALDI-TOF-MS Fingerprinting Provides Evidence of 
Urosepsis caused by Aerococcus urinae
Jieun Kim, Sung Kuk Hong, Myungsook Kim, Dongeun Yong, and Kyungwon Lee
Department of Laboratory Medicine, Research Institute of Bacterial Resistance, Yonsei University College of Medicine, Seoul, Korea
Urosepsis due to Aerococcus urinae is rare in clinical settings with only a few of reported cases worldwide by 16S rRNA se-
quencing. Here we report a case of sepsis caused by A. urinae in a 86 year-old male with complicated urinary tract infection 
which was confirmed through peptide mass fingerprinting of matrix-assisted laser desorption ionization time of flight mass spec-
trometry.
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Case Report
Introduction
Urosepsis is defined as sepsis caused by a urogenital tract in-
fection (UTI), which accounts for approximately 25% of all 
sepsis cases in adults, and most cases are due to complicated 
UTIs [1]. The bacterial spectrum in urosepsis is composed of 
61% Escherichia coli, 16% other Enterobacteriaceae, 8% Staph-
ylococcus aureus and 6% enterococci [2]. However, if the host 
immune system is suppressed, less virulent organisms, such as 
enterococci, coagulase- negative staphylococci or Pseudomo-
nas aeruginosa, can cause urosepsis. 
Aerococcus urinae is known to colonize the human urinary 
tract and may cause symptomatic UTI [3], infective endocar-
ditis [4] and bacteremia [5]. However, sepsis due to UTI by A. 
urinae is not commonly recognized in clinical settings and in-
adequate treatment of this infection has been linked to fatal 
outcomes and severe complications [6]. Here, we report a case 
of urosepsis due to A. urinae identified through matrix-assist-
ed laser desorption ionization time of flight mass spectrome-
try (MALDI-TOF-MS).
Case Report
An 86-year-old man was admitted to the hospital with both 
feet edema and generalized weakness of 15 days with elevated 
creatinine, suggesting the acute aggravation of chronic renal 
failure. He also had diabetes mellitus for more than 10 years 
and history of treated prostate cancer. On day 2 of hospitaliza-
tion his fever spiked to 38.1℃ and blood and urine cultures 
were drawn. The growth was detected in one anaerobic blood 
culture bottle (BacT/ALERT, bioMérieux, Marcy-l'Etoile, 
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France) out of three total pairs of blood cultures. Grayish pin-
point-sized alpha-hemolytic colonies grew on blood agar and 
Gram-positive cocci in clusters were observed on microscopy. 
His urine culture grew, >105 CFU/mL of a similar organism 
with >105 CFU/mL of E. coli. The isolates from blood and 
urine culture were identified as A. urinae by the VITEK 2 sys-
tem GP (Gram-positive) II card (bioMérieux).
16S rRNA gene sequencing and MALDI-TOF-MS (Bruker 
Daltonik GmbH, Bremen, Germany) further confirmed the 
identification of the organisms. The 16S rRNA gene sequences 
of the two isolates were identical to each other (783 bp) and 
were 99.2% similar to A. urinae (GenBank accession no. 
M778191), differed from Aerococcus christensenii (no. Y17005) 
with 94.1% similarity, and Aerococcus sanguinicola (no. 
AJ276512) with 94.0% similarity in EzTaxon e-database (http://
www.ezbiocloud.net/eztaxon). Since the separation between 
different species was greater than 0.8%, A. urinae was consid-
ered as acceptable identification [7]. MALDI-TOF-MS analysis 
yielded isolates from blood and urine by scores of 2.216 and 
2.141, respectively on Biotyper 3.1 (Bruker Daltonik GmbH), 
greater than 2.00, which can be considered an excellent proba-
bility for identification. The mass spectrum and peak heights 
were identical to each other and all m/z difference between 
two isolates were less than 500 ppm (difference range, 0.063-
474.608), which is the limit of mass tolerance (Fig. 1A, B).
The antimicrobial susceptibility of the two isolates was test-
ed according to the disk diffusion interpretive criteria of Strep-
tococcus spp. viridans group provided by the Clinical and Lab-
oratory Standards Institute. Both isolates were susceptible to 
penicillin, ceftriaxone, cefepime, clindamycin, erythromycin, 
teicoplanin and vancomycin with identical antibiogram.
The patient underwent antimicrobial therapy with ceftriax-
one for five days then changed to meropenem after growing of 
E. coli on urine culture. Two days later, teicoplanin was added 
after growth of A. urinae was reported from blood and urine 
cultures. In the subsequent cultures, A. urinae was not detect-
ed, he discharged after 19 days of antimicrobial treatment. 
Figure 1. (A) Peptide mass fingerprinting by MALDI-TOF-MS of Aerococcus urinae from blood culture; (B) peptide mass finger-
printing by MALDI-TOF-MS of A. urinae from urine culture. 
MALDI-TOF-MS, matrix-assisted laser desorption ionization time of flight mass spectrometry.       
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Discussion
A. urinae is facultatively anaerobic, catalase-negative and 
alpha-hemolytic Gram-positive cocci that forms tetrads and 
clusters. For its features of both Staphylococcus and Strepto-
coccus, the secure identification of aerococci has relied on 16S 
rRNA gene sequencing, however, correct and fast identifica-
tion is allowed with MALDI-TOF-MS with high sensitivity and 
specificity [8]. 
To determine the relatedness of isolates that cause simulta-
neous infection, genetic typing methods with high discrimina-
tory power are conventionally used, but are time-consuming 
and cost-intensive. The peptide mass fingerprinting of MALDI-
TOF-MS facilitates the identification of clonality rapidly with 
accuracy and reproducibility, and therefore might be used as 
a definitive tool to track course of infection. 
To the best of our knowledge, this report adds a first patient 
confirmed by MALDI-TOF-MS to the published reports of 
urosepsis caused by A. urinae which were determined by an-
tibiogram [9] or 16S rRNA sequencing [10]. There have been 
several studies examining the clinical significance of A. uri-
nae, but these have not been conclusive, and it is still known 
as a non-virulent organism which might be able to be treated 
without antimicrobial treatment [3] or an organism which can 
cause invasive infection with mortality [6]. However, with the 
aid of peptide mass fingerprinting by MALDI-TOF-MS, we 
suggest that A. urinae acts as an invasive pathogen, which in-
fected the bloodstream of a patient with a complicated UTI.
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